drugset / Trial / NCT01055106

Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

NCT01055106

Phase 2 Completed 255 enrolled Graceway Pharmaceuticals, LLC
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to evaluate the efficacy and safety of GW05 administered in 3 regimens versus metronidazole 0.75% for the treatment of bacterial vaginosis.

Timeline

Start
2010-01
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 0.75 % Other
Comparator Metronidazole Small molecule 1.3 % Other

Indications